Intra-articular injection of hyaluronic acid (MW 1,500–2,000 kDa; HyalOne®) in symptomatic osteoarthritis of the hip: a prospective cohort study
- 681 Downloads
Clinical trials have demonstrated the safety and efficacy of hyaluronic acid-based products for the treatment of hip osteoarthritis, but data from observational studies of normal medical practice are scarce. This study investigated the long-term efficacy and tolerability of ultrasound-guided intra-articular sodium hyaluronate (MW 1,500–2,000 kDa; Hyalone®) injections in daily clinical practice.
In this observational, cohort study of patients with hip osteoarthritis, Hyalone® was administered under the ultrasound guidance, every 6 months, with the possibility of an additional injection at the intervening 3-month intervals on clinical request. Efficacy measurements included the Lequesne algofunctional index, self-reported pain via the visual analogue scale (VAS), the concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) and safety. The patients were followed up for 18 months after the first intra-articular injection.
Data from 120 patients were collected. During the study, a statistically significant reduction in algofunctional indexes was demonstrated at 3 months after study product injection, while at 12 months 80% of the patients achieved a decrease of at least 30% in symptoms. These results were maintained over time through cyclical and personalized repetition of ultrasound guided injections, at least one injection every 6 months.
The study treatment reduced pain and improved mobility in osteoarthritis of the hip. These results in daily clinical practice demonstrate a beneficial effect and the safety of the study product and suggest adding intra-articular injections of HyalOne® to the armamentarium of conservative management of symptomatic hip osteoarthritis.
KeywordsHyaluronic acid Hip Osteoarthritis Intra-articular injection Ultrasound guidance
American College of Rheumatology
Body mass index
Non-steroidal anti-inflammatory drug
Randomised controlled trial
Receiver operating characteristic
Visual analogue scale
Data collection and analysis, the reporting and writing of this study were supported by a grant from Fidia Farmaceutici S.p.A. No equipment or other supplies were provided by Fidia Farmaceutici S.p.A. The authors declare no conflict of interest with respect to the contents of this article.
Conflict of interest
The authors declare that they have no competing interests.
- 1.Symmons D, Mathers C, Pfleger B (2003) Global burden of osteoarthritis in the year 2000. World Health Organization, GenevaGoogle Scholar
- 5.Wang C-T, Lin J, Chang C-J et al (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. JBJS 86A(3):538–545Google Scholar
- 10.Schieb F (2003) Intraartikulär injizierte Hyaluronsäure bei Arthropathien. Arthritis rheum 23(6):338–340Google Scholar
- 11.Foti C, Cisari C, Carda S, Giordan N, Rocco A, Frizziero A, Della Bella G (2011) A prospective observational study of the clinical efficacy and safety of intra-articular sodium hyaluronate in synovial joints with osteoarthritis. Eur J Phys Rehabil MedGoogle Scholar
- 12.Priano F, Guelfi M (2007) Efficacy of intra-articular hyaluronic acid (Hyalubrix®) in arthroscopy. Artroscopia VIII(no. 1):3–12Google Scholar
- 13.Smiderle C, Scapin M, Ronconi L, Baldo M, Villaminar R (2007) Gait analysis of changes in clinical and biomechanical parameters in osteoarthritis knee patients after intra-articular infiltration with hyaluronic acid h.m.w. Eur Med Phys 43(Suppl 1–3):5–17Google Scholar
- 16.Jackson DW, Evans NA, Thomas BM (2002) Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 84A(9):1522–1527Google Scholar
- 21.Migliore A, Massafra U, Iannessi F, Capuano A, Diaco ML, Mascheroni E, Alimonti A, Granata G, Padalino C, Tormenta S 2006 Efficacy and safety of hyalubrix® administration in hip osteoarthritis: prospective cohort study. Ann Rheum Dis. 65 (Suppl II)Google Scholar
- 22.Migliore A, Bizzi E, Massafra U, Alimonti A, Martin-Martin S, Tormenta S (2008) 18-months followup after intra-articular administration of hyalubrix® in 344 patients with symptomatic osteoarthritis of the hip. Osteoarthr Cartil 16:118–119Google Scholar
- 23.Migliore A, Massafra U, Bizzi E, Vacca F, Martin–Martin S, Granata M, Alimonti A, Tormenta S (2009) Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther 11(6):R183PubMedCrossRefGoogle Scholar
- 27.Tormenta S, Migliore A, Nardis P et al (2004) Ultrasound pattern in a cohort of 170 patients suffering from hip osteoarthritis. Osteoarthr Cartil 12(B):P305 S124Google Scholar
- 31.Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669–681PubMedCrossRefGoogle Scholar